Oxford Nanopore Technologies (LON:ONT) Reaches New 52-Week Low Following Analyst Downgrade

Posted by Stacy Sanders on Jul 13th, 2026

Oxford Nanopore Technologies plc (LON:ONT – Get Free Report)’s stock price reached a new 52-week low on Monday after Citigroup downgraded the stock to a buy rating. The company traded as low as GBX 95.61 and last traded at GBX 99.19, with a volume of 10534120 shares trading hands. The stock had previously closed at GBX 120.30.

Separately, Royal Bank Of Canada reiterated an “outperform” rating and set a GBX 225 price target on shares of Oxford Nanopore Technologies in a report on Tuesday, May 26th. Four analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of GBX 218.60.

View Our Latest Analysis on Oxford Nanopore Technologies

Insiders Place Their Bets

In other Oxford Nanopore Technologies news, insider Nick Keher sold 22,993 shares of the business’s stock in a transaction dated Tuesday, April 14th. The stock was sold at an average price of GBX 108, for a total value of £24,832.44. Over the last ninety days, insiders bought 22,799 shares of company stock valued at $2,578,133. 2.54% of the stock is currently owned by insiders.

Oxford Nanopore Technologies Stock Down 15.7%

The company has a quick ratio of 6.01, a current ratio of 3.56 and a debt-to-equity ratio of 8.96. The company has a market cap of £988.90 million, a PE ratio of -6.72 and a beta of 0.92. The company’s fifty day moving average is GBX 123.34 and its 200-day moving average is GBX 128.12.

About Oxford Nanopore Technologies

(Get Free Report)

Oxford Nanopore Technologies’ goal is to bring the widest benefits to society through enabling the analysis of anything, by anyone, anywhere. The Group has developed a new generation of nanopore-based sensing technology that is currently used for real-time, high-performance, accessible, and scalable analysis of DNA and RNA. The technology is used in more than 125 countries, to understand the biology of humans, plants, animals, bacteria, viruses and environments as well as to understand diseases such as cancer.